Contact

Invitation: Live Presentation with Richard Paxman – Q2 2026

PAXMAN will publish its report for the second quarter of 2026 on August 21 at 7:00 a.m. CEST. A live presentation for investors, analysts and the media will be held on the same day at 9:00 a.m. CEST.

During the presentation, CEO Richard Paxman will comment on the report. The Q&A session will be moderated by Maria Karlsson Osipova. The presentation will be held in English.
The link to the presentation can be found here: https://access.dnbcarnegie.com/companies/1595/live

Invitation: Live Presentation with Richard Paxman – Q2 2026 Invitation: Live Presentation with Richard Paxman – Q2 2026
What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram